About NexEos Diagnostics
NexEos Diagnostics is a private company based in Chester Springs, Pennsylvania. It has reported $25,694,546 raised in five offerings on Form D since July 2019. Its chief executive is Stephen Tullman.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 2, 2026 | Feb 17, 2026 | $3,000,000fully sold | 19 | $157K | EquityRule 506(b) | Form D ↗ |
| May 23, 2024 | Jun 6, 2024 | $4,916,907fully sold | 22 | $223K | EquityRule 506(b) | Form D ↗ |
| Feb 14, 2023 | Feb 15, 2023 | $5,100,000fully sold | 19 | $268K | EquityRule 506(b) | Form D ↗ |
| Oct 1, 2021 | Oct 12, 2021 | $9,677,639fully sold | 21 | $460K | EquityRule 506(b) | Form D ↗ |
| Jul 3, 2019 | Jul 30, 2019 | $3,000,000of $5.5M target | 4 | $750K | Equity, OptionsRule 506(b) | Form D ↗ |
| Total, five offerings | $25,694,546 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on NexEos Diagnostics's Form D filed Feb 17, 2026.
TM
Theresa Mansi
Executive officer
CM
Christopher Molineaux
Director
LM
Louis Manzi
Director
DL
Dennis Langer
Director
JH
Jeff Himawan
Director
ST
Stephen Tullman
Chief Executive Officer and director
NS
Nicholas Siciliano
Director
Earlier filings also listed Nicholas Sicilano (director, last listed Oct 2021).